Abstract
The method to immortalize human T cells efficiently and reproduciblyby oncogene transfection was improved. T cells were first grown selectively from peripheralblood lymphocytes population of healthy donors andatopic asthma patients, and from lymph nodelymphocytes population of lung cancer patients byactivating with mitogens (phytohemagglutinin andconcanavalin A) and recombinant human interleukin-2(rhIL-2) for five days. Plasmids expressingoncogenes, such as c-Ha-ras, c-myc,c-fos, v-myb and v-jun under the controlof human cytomegalovirus promoter, were then introducedinto these stimulated lymphocytes either separately orin various combinations by electropolation. Afterculturing these transfected lymphocytes for recoveryfor 1 day, they were fed every 3–4 days. Although all the control cells died within one month,oncogene-transfected lymphocytes continued toproliferate actively even for more than severalmonths, indicating that oncogene-transfectedlymphocytes were successfully immortalized. Flowcytometric analyses revealed that most of theimmortalized lymphocytes were T cells expressingCD3+ surface antigen. The ratios of CD4+and CD8+ subpopulations in immortalized T cellsderived from healthy donors varied, depending onthe kinds of oncogenes used. However, CD8+subpopulation in immortalized T cells derived fromcancer patients and atopic asthma patients weredominant, independent of the kinds of oncogenes. These immortalized T cells showed differentproliferative responses in the presence or absence ofexogenous human rhIL-2, depending on their origin ofdonors. Furthermore, immortalized T cells derivedfrom healthy donors showed stronger cytotoxicityagainst K562 cells, suggesting that MHC-nonrestrictedkiller T cells in T cell population were alsoimmortalized. Immortalized T cell lines, whichproliferate continuously without stimulation of amitogen or antigen in medium containing a lowconcentration of rhIL-2, have been maintained for morethan 2 years without any growth rate decrease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alam S, Katakura Y and Shirahata S (1999) Establishment of human T cell clones exhibiting natural killer-like activity. Cytotechnology 31: 171–176.
Alam S, Katakura Y, Yoshida H, Kim E-H and Shirahata S (1997) Functional characterization of human T cells immortalized by oncogene transfection. Cytotechnology 23: 185–192.
Borek C (1980) X-ray-induced in vitro neoplastic transformation of human diploid cells. Nature 283: 776–778.
Hastie ND and Alshire RC (1989) Human telomeres: fusion and interstitial sites. Trends Genet 5: 326–331.
Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyzek MA, Shay JW, Ishioka S and Yamakido M (1995) Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 155: 3711–3715.
Jones CL and Kane MA (1996) Oncogenic signaling. Curr Opin Oncol 8: 54–59.
Joneson T and Bar-Saqi D (1997) Ras effectors and their role in mitogenesis and oncogenesis. J Mol Med 75: 587–593.
Murakami H, Masui H, Sato GH, Sueoka N, Chow TP and Kano-Sueoka T (1982) Growth of hybridoma cells in serum-free medium: ethanolamine is an essential component. Proc Natl Acad Sci USA 79: 1158–1162.
Murakami H, Okazaki Y, Yamada K and Omura H (1988) Egg yolk lipoprotein, a new supplement for the growth of mammalian cells in serum-free medium. Cytotechnology 1: 159–169.
Okano F, Tachibana H, Akiyama K and Murakami H (1993a) The detection of a breast cancer antigen on MCF-7 cells reactive with the TCR (alpha) of a specific killer T cell line. Biotherapy 6: 195–203.
Okano F, Tachibana H, Akiyama K, Shirahata S and Murakami H (1993b) Immortalization of human T lymphocytes by oncogenes. Cytotechnology 11: 205–211.
Pereira-Smith OM and Smith JR (1988) Genetic analysis of indefinite division in human cells: Identification of four complementation groups. Proc Natl Acad Sci USA 85: 6042–6046.
Rohme D (1981) Evidence for a relationship between longevity of mammalian species and life spans of normal fibroblasts in vitro and erythrocytes in vivo. Proc Natl Acad Sci USA 78: 5009–5013.
Russo J, Reina D, Frederick J and Russo IH (1988) Expression of phenotypical changes by human breast epithelial cells treated with carcinogens in vitro. Cancer Res 48: 2837–2857.
Shay JW and Wright WE (1989) Quantitation of the frequency of immortalization of normal human diploid fibroblasts by SV40 large T-antigen. Exp Cell Res 184: 109–118.
Smith JR and Pereira-Smith OM (1996) Replicative senescence: implications for in vivo aging and tumor suppression. Science 273: 63–67.
Smith KA (1980) T cell growth factor. Immunol Rev 51: 337–357.
Stevenson M, Volsky B, Hedenskog M and Volsky DJ (1986) Immortalization of human T lymphocytes after transfection of Epstein-Barr virus DNA. Science 233: 981–983.
Troidl B, Simmer B, Fickenscher H, Muller-Fleckenstein I, Emmrich F, Fleckenstein B and Gebhart E (1994) Karyotypic characterization of human T cell lines immortalized by Herpes virus saimiri. Intl. J Cancer 56: 433–438.
Weinberg RA (1985) The action of oncogenes in the cytoplasm and nucleus. Science 230: 770–776.
Wright WE, Pereira-Smith OM and Shay JW (1989) Reversible cellular senescence: Implication for immortalization of normal human diploid fibroblasts. Mol Cell Biol 9: 3088–3092.
Wright WE and Shay JW (1992) The two-stage mechanism controlling cellular senescence and immortalization. Exp Gerontol 27: 383–389.
Yano T, Teruya K, Shirahata S, Watanabe J, Osada K, Tachibana H, Ohashi H, Kim E-H and Murakami H (1994) Ras oncogene enhances the production of a recombinant protein regulated by the cytomegalovirus promoter in BHK-21 cells. Cytotechnology 16: 167–178.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Alam, S., Katakura, Y., Yoshida, H. et al. Improvement of a method to reproducibly immortalize human T cells by oncogene transfection. Cytotechnology 33, 71–81 (2000). https://doi.org/10.1023/A:1008171109981
Issue Date:
DOI: https://doi.org/10.1023/A:1008171109981